Novozymes A-S (B) Aktie
58,96
EUR
+0,56
EUR
+0,96
%
58,92
EUR
-0,84
EUR
-1,41
%
Werbung
Novozymes A-S (B) Aktie Analyse
03.09.12 | Novozymes A-S (B) buy | ING | |
28.08.12 | Novozymes A-S (B) overweight | Morgan Stanley | |
09.08.12 | Novozymes A-S (B) overweight | Morgan Stanley | |
19.06.12 | Novozymes A-S (B) overweight | Morgan Stanley | |
17.11.11 | Novozymes A-S (B) overweight | Morgan Stanley |
Werbung
Werbung